Designing for discovery: Study design and statistical power in high‑dimensional proteomics
In high‑dimensional proteomics, “more proteins” doesn’t automatically mean “more discovery.” The reliability of your findings still depends on study design choices that determine statistical power, reproducibility, and signal‑to‑noise—long before the first model is run.
In this webinar, we’ll cover practical strategies for building studies that hold up under biological and statistical scrutiny. We’ll discuss cohort and comparison‑group construction, sample size and power tradeoffs, and how to plan for key sources of unwanted variation—batch effects, plate structure, and sample handling—so they don’t overwhelm true biology. We’ll also address control selection, randomization and balancing, and common design pitfalls that limit validation.
Finally, we’ll connect design decisions to downstream analysis—when harmonization helps, how design impacts biomarker discovery, and what to document so results can be reproduced and integrated across studies. Join us to move from “analysis‑ready” data to discovery‑ready study plans that maximize what proteomics can tell you.
By the end of this session, you will be able to:
- Define the key design decisions that drive power, reproducibility, and interpretability in high‑dimensional proteomics studies
- Identify practical approaches to cohort construction, group matching, and sampling strategies that reduce confounding
- Plan controls, randomization, and balancing to mitigate batch, plate, and handling effects before data generation and analysis
- Estimate and justify sample size using power and variance considerations, including tradeoffs across endpoints and subgroups
- Create a documentation and analysis plan that supports validation, cross‑study integration, and transparent reporting

Will Schwarzmann
Bioinformatics Support Scientist, Illumina
Will Schwarzmann is a Bioinformatics Support Scientist at Illumina. Will supports customers through their proteomics journey from study design to statistical analysis. He additionally works in data consulting services for SomaScan Assay users. Prior to entering commercial proteomics, Will was a service researcher in academia, providing analysis for projects, mentoring students, and assisting at workshops.

Lena Cuddeback
Bioinformatics Scientist, Illumina
Lena is a bioinformatician specializing in study design, normalization, and data analysis, supporting projects from planning through interpretation. Beginning her career in genomic diagnostics R&D, she now focuses on proteomics, with an interest in biomarkers and disease mechanisms. She enjoys working with data and exploring advances in statistics and biology, particularly the complexity and variability underlying human health. She has her B.S. from California Polytechnic University, San Luis Obispo.
Designing for discovery: Study design and statistical power in high‑dimensional proteomics
A presentation by Will Schwarzmann, and Lena Cuddeback
More webinars
WebinarOpening the black box: Building and evaluating machine learning models for proteomics
Machine learning can be a powerful way to extract multivariate signals from high-dimensional proteomics data, but only when models are built and evaluated with rigor. In this on-demand webinar, explore a practical framework for developing predictive and explanatory models, with an emphasis on study design choices that help prevent data leakage, reduce overfitting, and improve reproducibility.
WebinarBeyond the trees: See the bigger biological picture with pathway enrichment analysis
Proteomic data holds enormous potential—but the biology is rarely contained in a single protein. When you’re handed a list of differentially abundant proteins, the next challenge is turning that list into a clear, testable story about mechanisms and processes.
WebinarFinding the signal: Identifying reproducible biomarkers in high-plex proteomics
In biomarker discovery, the challenge is rarely a lack of data. Rather, it is knowing how to separate meaningful biological signal from technical distraction. This webinar focuses on how to use univariate analysis as a practical and powerful entry point for biomarker discovery in high-plex proteomics studies.
